New device helps regulate blood sugar available in central Ohio

Published:
Updated:

Breakthrough technology is giving people with Type One diabetes greater control of the condition.

The new FDA approved hybrid closed loop insulin delivery system is being hailed as an “artificial pancreas."

It is essentially two devices working to keep blood sugar steady by predicting when a person's blood sugar is dropping and preventing it.

It also corrects when blood sugar is too high. Type one diabetes is a chronic condition that causes the pancreas to produce little or no insulin.

Janet Zappe is a diabetes educator at The Ohio State University Wexner Medical Center. She's helping people transition from the constant juggling act of checking their blood sugar and balancing their diet to the closed loop hybrid system.

Zappe said the sensor is one of the biggest advances she’s seen in 25 years.

“This product is going to take a lot of that burden of them. They still have to check their blood sugar but it's going to help making decisions," she said.

The Medtronic MiniMed 670G closed loop hybrid system means wearing two devices: an insulin pump and a continuous glucose monitor (CGM).

Right now the technology is approved for people 14 years old and older. There is also an issue around who can take advantage of it because some insurers do not cover it.

Organizations, including JDRF (Juvenile Diabetes Research Foundation), are working to get the word out about the benefits of this new system.